Early Win for PTSD Drug; FDA OKs AI Sleep Diagnostic; Extreme Social Isolation Tool

(MedPage Today) -- ALTO-100, an investigational drug that works to restore plasticity in the brain, yielded a larger reduction in CAPS-5 scores in patients with biomarker-defined post-traumatic stress disorder (PTSD) versus those without the biomarker...
Source: MedPage Today Psychiatry - Category: Psychiatry Source Type: news